`Patent 7,772,209
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`NEPTUNE GENERICS, LLC,
`APOTEX INC., APOTEX CORP., TEVA PHARMACEUTICALS,
`FRESENIUS KABI USA, LLC, and
`WOCKHARDT BIO AG
`Petitioners,
`
`v.
`
`ELI LILLY & COMPANY,
`Patent Owner.
`__________________
`
`Case No: IPR2016-002371
`Patent No. 7,772,209
`__________________
`
`
`
`PATENT OWNER’S NOTICE OF DEPOSITION OF
`W. ARCHIE BLEYER, M.D.
`
`
`
`
`
`
`1 Cases IPR2016-01190, IPR2016-01335, and IPR2016-01341 have been joined
`
`with the instant proceeding.
`
`
`
`
`
`Case IPR 2016-00237
`Patent 7,772,209
`Pursuant to 37 C.F.R. § 42.53, Patent Owner Eli Lilly & Company (“Lilly”)
`
`by and through their attorneys will conduct cross-examination by deposition of W.
`
`Archie Bleyer, M.D. Dr. Bleyer’s deposition will take place, as agreed by counsel
`
`for the parties, on January 31, 2017, commencing at 8:00 a.m., or such other time
`
`as may be agreed by counsel, at Skiermont Derby LLP, 2200 Ross Ave., Ste.
`
`4800W, Dallas, Texas 75201. Counsel for Petitioner Neptune Generics, LLC has
`
`represented that Dr. Bleyer is willing to appear at the time and location indicated
`
`above.
`
`The cross-examination will be taken before a Notary Public or other officer
`
`authorized by law to administer oaths. It will be recorded using audiotape and/or
`
`stenographic means. Patent Owner also intends to videotape the cross-examination
`
`of Dr. Bleyer. The arrangements for the court reporter who will record the
`
`deposition using audiotape and/or stenographic means as well as the videographer
`
`will be made by counsel for Patent Owner.
`
`
`
`
`
`Date: January 18, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/David M. Krinsky/
`David M. Krinsky
`Reg. No. 72,339
`Back-up Counsel for
`Patent Owner
`
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`
`
`
`2
`
`
`
`Case IPR 2016-00237
`Patent 7,772,209
`Washington, D.C. 20005
`202-434-5338 (Telephone)
`202-434-5029 (Facsimile)
`dkrinsky@wc.com
`
`
`
`3
`
`
`
`
`
`
`
`Case IPR 2016-00237
`Patent 7,772,209
`
`CERTIFICATE OF SERVICE
`(37 C.F.R. § 42.6(e))
`
`The undersigned hereby certifies that the foregoing document was served on
`
`
`
`January 18, 2017 by delivering a copy via electronic mail on the following
`
`attorneys of record for the Petitioners:
`
`Sarah E. Spires
`Reg. No. 61,501
`237Neptune@skiermontderby.com
`
`Skiermont Derby LLP
`2200 Ross Ave., Ste. 4800W
`Dallas, Texas 75201
`P: 214-978-6600/F: 214-978-6601
`
`Attorneys for Neptune Generics, LLC
`
`John D. Polivick
`Reg. No. 57,926
`jpolivick@rmmslegal.com
`
`William A. Rakoczy
`Pro hac vice to be filed
`wrakoczy@rmmslegal.com
`
`Rakoczy Molino Mazzochi Siwik LLP
`6 West Hubbard Street, Suite 500
`Chicago, IL
`P: 312-527-2157/F: 312-527-4205
`
`Attorneys for Apotex Inc. and Apotex
`Corp.
`
`Gary J. Speier
`Reg. No. 45,458
`gspeier@carlsoncaspers.com
`
`
`
`
`Dr. Parvathi Kota
`Reg. No. 65,122
`237Neptune@skiermontderby.com
`
`
`
`
`Deanne M. Mazzochi
`Reg. No. 50,158
`dmazzochi@rmmslegal.com
`
`Patrick C. Kilgore
`Reg. No. 69,131
`pkilgore@rmmslegal.com
`
`
`
`Mark D. Schuman
`Reg. No. 31,197
`mschuman@carlsoncaspers.com
`
`
`
`
`
`
`Case IPR 2016-00237
`Patent 7,772,209
`
`
`
`
`
`
`Bryan P. Collins
`Reg. No. 43,560
`bryan.collins@pillsburylaw.com
`
`
`/David M. Krinsky/
`David M. Krinsky
`Reg. No. 72,339
`Back-up Counsel for Patent
`Owner
`
`
`Date: January 18, 2017
`
`
`
`
`
`Carlson, Caspers, Vandenburgh,
`Lindquist & Schuman
`225 South Sixth Street, Suite 4200
`Minneapolis, MN 55402
`P: 612-436-9600
`F: 612-436-9605
`
`Cynthia Lambert Hardman
`Reg. No. 53,179
`chardman@goodwinprocter.com
`
`Goodwin Procter LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018-1405
`P: 212-813-8800
`F: 212-355-3333
`
`Attorneys for Teva Pharmaceuticals
`USA, Inc. and Kabi Fresenius USA,
`LLC
`
`Patrick A. Doody
`Reg. No. 35,022
`patrick.doody@pillsburylaw.com
`
`Pillsbury Winthrop Shaw Pittman LLP
`1650 Tysons Boulevard
`McLean, VA 22102
`P: 703-770-7755/F: 703-770-7901
`
`Counsel for Wockhardt Bio AG